China, Oct. 13 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Research on the development and application of radiopharmaceuticals targeting TROP2 in the diagnosis and treatment of bladder cancer'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600134270
Registration Time: 2026/10/12
Type: Interventional study
Primary Sponsor: The First Affiliated Hospital, Jinan University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=347045
Published by HT Digital Content Services with permission from Health Daily Digest....